From November 2019 to 2021, Mark Fettman, MD, a psychiatrist from Portland, Ore., allegedly knowingly conducted office-based opioid treatment without complying with state requirements, according to the report.
He allegedly operated his clinic two days a month and prescribed patients maximum legal dosages of buprenorphine, a Schedule III opioid. He accepted cash payments and money orders but did not accept insurance.
The charges include 137 counts of drug trafficking, nine counts of money laundering and one count of engaging in corrupt activity. Dr. Fettman’s arraignment is scheduled for May 1.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.